Suppr超能文献

用于识别骨量升高的改良标准。

Modified criteria for identifying elevated bone mass.

作者信息

Chen Jiangjie, Cao Lingling, Xu Chenghao, Lu Fangying, Zhang Liwei, Xu Anpeng, Chen Yahong, Tung Tao-Hsin, Hong Dun

机构信息

Bone Metabolism and Development Research Center, Taizhou Hospital Affiliated to Wenzhou Medical University, 150 Ximen St., Linhai, 317000, Zhejiang, China.

Department of Orthopedics, Taizhou Hospital Affiliated to Wenzhou Medical University, 150 Ximen St., Linhai, 317000, Zhejiang, China.

出版信息

Osteoporos Int. 2025 Jun 6. doi: 10.1007/s00198-025-07551-9.

Abstract

UNLABELLED

This study used modified criteria to exclude osteoporosis and osteopenia from elevated bone mass (EBM) to avoid a diagnostic paradox and demonstrated that diffuse idiopathic skeletal hyperostosis (DISH), severe lumbar degenerative disease (LDD), elevated body mass index (BMI), and diabetes are key risk factors for super EBM (SEBM).

PURPOSE

The current criteria classify individuals with both EBM and osteopenia/osteoporosis. To avoid this contradiction, we used a modified criterion to exclude osteoporosis or osteopenia from EBM and to examine the clinical impact and risk factors of EBM.

METHODS

In this retrospective study, bone mineral density (BMD) data from participants aged 18 years or older collected at a tertiary hospital between 2021 and 2023 were analyzed. Inclusion criteria were complete Z-scores and T-scores for the lumbar spine, femoral neck, and total hip. Participants with a history of lumbar spine surgery or hip arthroplasty prior to BMD measurement were excluded. Normal bone mass (NBM) was defined as T-scores ≥ -1.0 at all sites and Z-scores < 2.5 at any site. EBM was defined as NBM plus Z-scores ≥ 2.5 at any site. EBM was further subdivided into moderate EBM (MEBM) with Z-scores between 2.5 and 4.0, and SEBM with Z-scores ≥ 4.0. Demographic data, medical history, and comorbidities were collected and analyzed.

RESULTS

Of the 33,479 eligible participants, 1,472 (4.4%) were identified with EBM. The EBM group was divided into 1,267 (3.8%) with MEBM and 205 (0.6%) with SEBM. SEBM group had a significantly higher proportion of men and a higher BMI than the MEBM group (p < 0.001). In addition, SEBM group had a higher prevalence of conditions such as DISH, ankylosing spondylitis (AS), LDD, and diabetes (p < 0.001). Different correlation trends between BMI, T-scores, and Z-scores were observed in the SEBM and MEBM groups. Chi-squared Automatic Interaction Detection (CHAID) analysis identified DISH as the strongest predictor of SEBM, while severe LDD, increased BMI, and diabetes were contributing factors for SEBM.

CONCLUSIONS

Using the modified criteria for EBM, which exclude cases of osteoporosis and osteopenia, SEBM has a higher rate of comorbidities compared to MEBM. The presence of DISH, higher severity of LDD, increased BMI, and diabetes were identified as strong risk factor of SEBM.

摘要

未标注

本研究采用改良标准,将骨质疏松症和骨质减少症排除在骨量升高(EBM)之外,以避免诊断悖论,并证明弥漫性特发性骨肥厚(DISH)、严重腰椎退行性疾病(LDD)、体重指数(BMI)升高和糖尿病是超级EBM(SEBM)的关键危险因素。

目的

现行标准将同时患有EBM和骨质减少症/骨质疏松症的个体进行分类。为避免这种矛盾,我们使用改良标准将骨质疏松症或骨质减少症排除在EBM之外,并研究EBM的临床影响和危险因素。

方法

在这项回顾性研究中,分析了2021年至2023年在一家三级医院收集的18岁及以上参与者的骨密度(BMD)数据。纳入标准为腰椎、股骨颈和全髋的完整Z值和T值。排除在BMD测量前有腰椎手术或髋关节置换术史的参与者。正常骨量(NBM)定义为所有部位T值≥-1.0且任何部位Z值<2.5。EBM定义为NBM加上任何部位Z值≥2.5。EBM进一步细分为Z值在2.5至4.0之间的中度EBM(MEBM)和Z值≥4.0的SEBM。收集并分析人口统计学数据、病史和合并症。

结果

在33479名符合条件的参与者中,1472名(4.4%)被确定患有EBM。EBM组分为1267名(3.8%)MEBM患者和205名(0.6%)SEBM患者。SEBM组男性比例和BMI显著高于MEBM组(p<0.001)。此外,SEBM组DISH、强直性脊柱炎(AS)、LDD和糖尿病等疾病的患病率更高(p<0.001)。在SEBM组和MEBM组中观察到BMI、T值和Z值之间不同的相关趋势。卡方自动交互检测(CHAID)分析确定DISH是SEBM的最强预测因素,而严重LDD、BMI升高和糖尿病是SEBM的促成因素。

结论

使用排除骨质疏松症和骨质减少症病例的EBM改良标准,SEBM的合并症发生率高于MEBM。DISH的存在、LDD的更高严重程度、BMI升高和糖尿病被确定为SEBM的强危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验